Drugs News and Research

RSS

Hsp90 protein appears to stimulate exosome release

Researchers from the Verstreken lab have identified a completely novel function for Hsp90, one of the most common and most studied proteins in our body.

7 Sep 2018

Insulin’s high cost leads to deadly rationing

Diabetic ketoacidosis is a terrible way to die. It’s what happens when you don’t have enough insulin. Your blood sugar gets so high that your blood becomes highly acidic, your cells dehydrate, and your body stops functioning.

7 Sep 2018

Certain cells in hippocampus play key role in risk taking behavior and anxiety

Why do some people comfortably walk between skyscrapers on a high-wire or raft the Niagara Falls in a wooden barrel whereas others freeze on the mere thought of climbing off escalators in a shopping mall? In a new study, scientists have found that a certain type of cells in the hippocampus play a key role.

7 Sep 2018

Scientists discover key aspect in the development of multiple sclerosis

In multiple sclerosis, not only the T cells of the immune system, but also its B cells, play an important role.

7 Sep 2018

Researchers develop rapid, cost-effective method to create human cortical organoids

Writing in the current online issue of the journal Stem Cells and Development, researchers at University of California San Diego School of Medicine describe development of a rapid, cost-effective method to create human cortical organoids directly from primary cells.

7 Sep 2018

FDA Commissioner's statement on implementing the update to iconic Nutrition Facts label

Advancing better nutrition is one of my top priorities and implementing the update to the iconic Nutrition Facts label - the first overhaul in 20 years - is a key part of that commitment.

7 Sep 2018

New study aims to understand why skin grafts have high rate of rejection

When it comes to transplant rejection, some organs are far trickier than others. Some transplantable organs, such as the liver, are readily accepted by the recipient's immune system, rarely triggering an immune response and rejection

7 Sep 2018

UNC and Cell Microsystems receive NIH Phase I SBIR contract to develop HIV diagnostic assay

The University of North Carolina at Chapel Hill HIV Cure Center and Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced they have received an approximately $283,000, 12-month Phase I Small Business Innovation and Research contract from the National Institutes of Health to develop an automated platform to quantify the latent HIV reservoir.

7 Sep 2018

Mayo Clinic collaborates with seven hospitals to establish not-for-profit generic drug company

Mayo Clinic joins a coalition of seven hospitals in launching Civica Rx, a not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications. The company, which is organized as a Delaware nonstock, not-for-profit corporation, will be headquartered in Utah.

7 Sep 2018

Research team identifies new therapeutic target for castration-resistant prostate cancer

A collaborative research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor expression in prostate cancer cells, identifying a new therapeutic target for one of the deadliest forms of cancer among men.

7 Sep 2018

Ground-breaking therapeutic process can destroy bowel cancer cells

Researchers at Queen's University Belfast have discovered a ground-breaking therapeutic process that can target and kill bowel cancer cells, which may improve survival rates for bowel cancer patients globally.

6 Sep 2018

Podcast: KHN’s ‘What the Health?’ Health policy goes to court

A federal judge in Texas seemed sympathetic to the argument by GOP state officials that the Affordable Care Act soon will no longer be constitutional since Congress eliminated the penalty for not having insurance. The case was filed by 18 state attorneys general and two governors.

6 Sep 2018

Single dose of influenza drug can shorten duration of illness, study reveals

A single dose of a new influenza drug can significantly shorten the duration of the illness in teens and adults, according to a study published in the prestigious New England Journal of Medicine.

6 Sep 2018

Research uncovers how the immune system detects DNA damage

Our immune system is working every day to protect us from bacteria, viruses, and parasites, but it can also detect when our own cells are damaged.

6 Sep 2018

USC scientists develop new way to identify molecular markers of breast cancer tumors

A research team led by USC scientists has developed a new way to identify molecular markers of breast cancer tumors, a potentially life-saving breakthrough that could lead to better treatment for millions of women.

6 Sep 2018

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, a clinical-stage rare disease and oncology company focused on sourcing and developing innovative treatments for underserved patient populations, announced today that the companies have entered into a global clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining BeiGene's investigational RAF dimer inhibitor, lifirafenib and SpringWorks Therapeutics' investigational MEK inhibitor, PD-0325901, in patients with advanced solid tumors.

6 Sep 2018

Lymph node structural cells exert control over T cell responses

Until now, the study of the immune system has focused almost exclusively on white blood cells, and T cells in particular, as the body’s major infection fighters.

6 Sep 2018

Study reaffirms success of conditional release programs for criminally insane individuals

After being found not guilty by reason of insanity, it's not typically a crime - rather declining mental health or breaking rules of conditional release like not drinking alcohol - that puts people back in a psychiatric hospital or even jail, researchers say.

6 Sep 2018

Study examines unnecessary medicine use in patients with advanced lung cancer

Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens.

6 Sep 2018

Breakthrough fluorine discovery may impact how pharmaceutical companies develop new drugs

A groundbreaking discovery by chemists at The University of Texas at San Antonio will have a significant impact on how pharmaceutical companies develop new drug treatments.

6 Sep 2018

Drugs News and Research

Hsp90 protein appears to stimulate exosome release

Insulin’s high cost leads to deadly rationing

Certain cells in hippocampus play key role in risk taking behavior and anxiety

Scientists discover key aspect in the development of multiple sclerosis

Researchers develop rapid, cost-effective method to create human cortical organoids

FDA Commissioner's statement on implementing the update to iconic Nutrition Facts label

New study aims to understand why skin grafts have high rate of rejection

UNC and Cell Microsystems receive NIH Phase I SBIR contract to develop HIV diagnostic assay

Mayo Clinic collaborates with seven hospitals to establish not-for-profit generic drug company

Research team identifies new therapeutic target for castration-resistant prostate cancer

Ground-breaking therapeutic process can destroy bowel cancer cells

Podcast: KHN’s ‘What the Health?’ Health policy goes to court

Single dose of influenza drug can shorten duration of illness, study reveals

Research uncovers how the immune system detects DNA damage

USC scientists develop new way to identify molecular markers of breast cancer tumors

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

Lymph node structural cells exert control over T cell responses

Study reaffirms success of conditional release programs for criminally insane individuals

Study examines unnecessary medicine use in patients with advanced lung cancer

Breakthrough fluorine discovery may impact how pharmaceutical companies develop new drugs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News